Product Categories
| Country: | United States |
|---|---|
| Tel: | +1-781-999-5354 |
| Mobile: | +17819995354 |
| E-mail: | marketing@targetmol.com |
| QQ: | |
| Skype: | Chat Now! |
| Address: | 36?Washington?Street, Wellesley?Hills |
|
Target Molecule Corp. (TargetMol) is a global high-tech enterprise, headquartered in Boston, MA, specializing in chemical and biological research product and service to meet the research needs of global customers.
TargetMol has evolved into one of the biggest global compound library and small molecule suppliers and a customer based on 40+ countries. TargetMol offers over 80 types of compound libraries and a wide range of high-quality research chemicals including inhibitors, activator, natural compounds, peptides, inhibitory antibodies, and novel life-science kits, for laboratory and scientific use. Besides, virtual screening service is also available for customers who would like to conduct the computer-aided drug discovery.
|
|
| Product Name | MF | CAS | Details |
|---|
| Lerociclib dihydrochloride | C26H35ClN8O | 2097938-59-3 | Details |
| Lerociclib | C26H34N8O | 1628256-23-4 | Details |
| G6PD activator AG1 | C24H30N4S2 | 421581-52-4 | Details |
| G3-C12 | C74H115N23O23S2 | 848301-94-0 | Details |
| Clorsulon | C8H8Cl3N3O4S2 | 60200-06-8 | Details |
| GABAA receptor agent 1 | C13H8ClN3O2 | 1571-87-5 | Details |
| Galanthamine N-Oxide | C17H21NO4 | 134332-50-6 | Details |
| Amylase | 9000-92-4 | Details |
| gamma-secretase modulator 1 | C24H24N4OS | 1172637-87-4 | Details |
| Gallopamil hydrochloride | C28H41ClN2O5 | 16662-46-7 | Details |
| Gallopamil | C28H40N2O5 | 16662-47-8 | Details |
| Gambogellic acid | C38H44O8 | 173867-04-4 | Details |
| Gamitrinib TPP | C52H65N3O8P+ | 1131626-46-4 | Details |
| Gamitrinib TPP hexafluorophosphate | C52H65F6N3O8P2 | 1131626-47-5 | Details |
| Gastrofensin AN 5 free base | C19H21ClN2O2 | 89845-16-9 | Details |
| GB-88 | C32H42N4O4 | 1416435-96-5 | Details |
| G907 | C26H24ClNO3 | 2244035-16-1 | Details |
| Gamma-glutamylcysteine TFA；Gamma-glutamylcysteine (TFA);γ-glutamylcysteine (TFA) | C20H32N6O12S2 | 283159-88-6 | Details |
| gamma-secretase modulator 2 | C25H22F4N6O2 | 1093978-89-2 | Details |
| gamma-secretase modulator 3 | C24H23FN4OS | 1431697-84-5 | Details |
| γ-Secretase modulator 4 | C23H19FN4O2 | 1420200-82-3 | Details |
| gamma-Secretase Modulators；Amyloid-β production inhibitor;γ-Secretase Modulators | C26H24F3N3O3 | 937812-80-1 | Details |
| Galidesivir triphosphate；BCX6870;Immucillin-A triphosphate;BCX4430-triphosphate | C11H18N5O12P3 | 1467740-78-8 | Details |
| Ganoderic acid F | C32H42O9 | 98665-15-7 | Details |
| GATA4-NKX2-5-IN-1 | C21H23N3O2 | 544681-96-1 | Details |
| GABAB receptor antagonist 1 | C18H24O4 | 797-17-1 | Details |
| Garcinol | C38H50O6 | 78824-30-3 | Details |
| Ganoderic acid TR | C30H44O4 | 862893-75-2 | Details |
| Ganodermanontriol | C30H48O4 | 106518-63-2 | Details |
| GB-110 | C33H48N6O5 | 1252806-70-4 | Details |
| Genz-123346 | C52H82N4O14 | 943344-58-9 | Details |
| Salbutamol；AH-3365;Albuterol | C13H21NO3 | 18559-94-9 | Details |
| GKA50 | C26H28N2O6 | 851884-87-2 | Details |
| GDC-0834 | C33H36N6O3S | 1133432-49-1 | Details |
| Gefitinib-d8；ZD1839 D8;Gefitinib D8 | C22H24ClFN4O3 | 857091-32-8 | Details |
| Gefitinib N-oxide | C22H24ClFN4O4 | 847949-51-3 | Details |
| Gemcabene calcium；PD-72953 calcium | C16H32CaO5 | 209789-08-2 | Details |
| GCN2-IN-1 | C19H18N10O | 1448693-69-3 | Details |
| GET73 | C13H16F3NO2 | 202402-01-5 | Details |
| Gemilukast | C36H37F2NO5 | 1232861-58-3 | Details |
| Gemcabene | C16H30O5 | 183293-82-5 | Details |
| GCN2-IN-6 | C19H12Cl2F2N4O3S | 2183470-09-7 | Details |
| GC 14 | C26H27NO6 | 447415-34-1 | Details |
| GBR 12783 | C28H32N2O | 67469-57-2 | Details |
| GC7 Sulfate | C8H22N4O4S | 150417-90-6 | Details |
| GDC-0834 Racemate | C33H36N6O3S | 1133432-46-8 | Details |
| Gisadenafil besylate；UK 369003-26 | C29H39N7O8S2 | 334827-98-4 | Details |
| Giredestrant；GDC-9545 | C27H31F5N4O | 1953133-47-5 | Details |
| GFB-8438 | C16H14ClF3N4O2 | 2304549-73-1 | Details |
| GGTI298 | C27H33N3O3S | 180977-44-0 | Details |
| Doxycycline hydrochloride；Hyclate;Vibramycin;Doxylin | C22H25ClN2O8 | 10592-13-9 | Details |
| Gemfibrozil 1-O-β-glucuronide | C21H30O9 | 91683-38-4 | Details |
| GCN2iB | C18H12ClF2N5O3S | 2183470-12-2 | Details |
| Taurocholic acid sodium salt hydrate；Taurocholic Acid sodium hydrate;Sodium taurocholate hydrate | C26H46NNaO8S | 345909-26-4 | Details |
| GDC-0834 S-enantiomer | C33H36N6O3S | 1133432-50-4 | Details |
| GDC-0276 | C24H31FN2O4S | 1494581-70-2 | Details |
| GF 15 | C23H21ClO6 | 888042-13-5 | Details |
| Germacrene D | C15H24 | 23986-74-5 | Details |
| Gepotidacin；GSK2140944 | C24H28N6O3 | 1075236-89-3 | Details |
| GENZ-882706；RA03546849 | C26H25N5O3 | 2070864-35-4 | Details |
| Ginsenoside Ra3 | C59H100O27 | 90985-77-6 | Details |
| GGTI-2418 | C23H31N5O4 | 501010-06-6 | Details |
| Pictilisib dimethanesulfonate | C24H30N7O6S3 | 957054-33-0 | Details |
| GDP-?α-D-?mannose disodium | C16H23N5Na2O16P2 | 148296-46-2 | Details |
| GDP366 | C20H17N5OS | 501698-03-9 | Details |
| GDC-0927；SRN-927 | C28H28FNO4 | 1642297-01-5 | Details |
| Gln-AMS | C15H22N8O8S | 209543-57-7 | Details |
| Fenbendazole | C15H13N3O2S | 43210-67-9 | Details |
| GLP-26 | C19H17F2N3O3 | 2133017-36-2 | Details |
| GLP-1 receptor agonist 2 | C30H31ClFN5O4 | 2230197-64-3 | Details |
| TT-OAD2 free base | C50H47Cl2N3O6 | 1246826-07-2 | Details |
| GLP-1 receptor agonist 1 | C48H48F2N10O5 | 2212020-52-3 | Details |
| GLP-1 receptor agonist 3 | C31H30FN5O4 | 2230200-09-4 | Details |
| GLP-1 receptor agonist 4 | C51H44Cl2N4O6 | 1187061-62-6 | Details |
| Clindamycin phosphate | C18H34ClN2O8PS | 24729-96-2 | Details |
| Glucagon receptor antagonists-2 | C22H30FNO2 | 202917-18-8 | Details |
| Glucagon receptor antagonists-3 | C22H30FNO2 | 202917-17-7 | Details |
| Glucagon receptor antagonists-5 | C30H29ClF3N3O3 | 2200274-63-9 | Details |
| GLPG0492 | C19H14F3N3O3 | 1215085-92-9 | Details |
| GLPG1205 | C22H22N2O4 | 1445847-37-9 | Details |
| Glutaminase-IN-1；CB839 derivative | C26H24F3N7O3Se | 2247127-79-1 | Details |
| IPN60090 | C24H27F3N8O3 | 1853164-83-6 | Details |
| Glyco-Obeticholic acid | C28H47NO5 | 863239-60-5 | Details |
| Antibacterial compound 2 | C22H30FN5O6 | 170104-58-2 | Details |
| Glucagon receptor antagonists-1 | C29H34FNO2 | 503559-84-0 | Details |
| Glycosidase-IN-1 | C13H23NO5 | 170376-12-2 | Details |
| Glucocorticoid receptor agonist | C20H20F4N2O2 | 1245526-82-2 | Details |
| Glucokinase activator 1 | C27H20F2N2O7S2 | 1328987-85-4 | Details |
| Glycosidase-IN-2 | C13H23NO5 | 476310-39-1 | Details |
| Glyoxalase I inhibitor free base | C21H29BrN4O8S | 174568-92-4 | Details |
| Carbenicillin disodium | C17H19N2NaO6S | 4800-94-6 | Details |
| O6BTG-octylglucoside；Glucose-conjugated MGMT inhibitor | C24H34BrN5O7S | 382607-78-5 | Details |
| GLUT4 activator 1 | C23H21FN4O3S | 2253733-37-6 | Details |
| Glutaminyl Cyclase Inhibitor 4 | C22H33N5O3 | 2376329-36-9 | Details |
| Glutaminyl Cyclase Inhibitor 1 | C21H24FN3O2 | 2110449-60-8 | Details |
| Glutaminyl Cyclase Inhibitor 2 | C19H20FN3 | 1884546-29-5 | Details |
| Glutaminyl Cyclase Inhibitor 3 | C24H32N6O2S | 2092921-50-9 | Details |
| GLPG0492 (R enantiomer)；GLPG0492 R enantiomer | C19H14F3N3O3 | 1215085-93-0 | Details |
| Gly-β-MCA | C26H43NO6 | 66225-78-3 | Details |
| Glycolic acid oxidase inhibitor 1 | C16H10BrNO3 | 77529-42-1 | Details |
| Product Total： Product Page： | ||||
| 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 66 67 68 69 70 71 72 73 74 75 76 77 78 79 80 81 82 83 84 85 86 87 88 89 90 91 92 93 94 95 96 97 98 99 100 101 102 103 104 105 106 107 108 109 110 111 112 113 114 115 116 117 118 119 120 121 122 123 124 125 | ||||